# Comparing Super High-flux and High-flux Dialyzer Performance Among Hemodialysis Patient With Sepsis : a Randomized Control Trial

Study · id `cardio:ct-nct06989892` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT06989892](<https://clinicaltrials.gov/study/NCT06989892>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT06989892

Browse, organ or system: Kidneys  
Browse, condition area: Kidney connections  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 202 participants.

## Technical summary

Registry record NCT06989892. Randomized; single masking; primary purpose treatment. Start 2024-07-25 (actual); primary completion 2026-07-01 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; single masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 202 participants (planned count; ClinicalTrials.gov record NCT06989892, source copy `cardio:ctgov-nct06989892-2025-05-25`, retrieved 2026-10-26)
- Started: 2024-07-25 (actual) (ClinicalTrials.gov record NCT06989892, source copy `cardio:ctgov-nct06989892-2025-05-25`, retrieved 2026-10-26)
- Primary completion: 2026-07-01 (anticipated) (ClinicalTrials.gov record NCT06989892, source copy `cardio:ctgov-nct06989892-2025-05-25`, retrieved 2026-10-26)
- Completion: 2026-10-01 (anticipated) (ClinicalTrials.gov record NCT06989892, source copy `cardio:ctgov-nct06989892-2025-05-25`, retrieved 2026-10-26)
- Countries: Thailand (ClinicalTrials.gov record NCT06989892, source copy `cardio:ctgov-nct06989892-2025-05-25`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct06989892-2025-05-25`, retrieved 2026-10-26)

## The registry's words

- Brief title: Comparing Super High-flux and High-flux Dialyzer Performance Among Hemodialysis Patient With Sepsis : a Randomized Control Trial
- Condition: The Efficacy and Safety for Super High-flux Dialyzer in Case of Sepsis in ESKD
- Condition: End Stage Kidney Disease (ESRD)
- Condition: Sepsis
- Intervention (Device): Super High-flux dialyzer (Elisio 19HDx)
- Intervention (Device): High-flux dialyzer (Elisio 19H)
- Lead sponsor: Navamindradhiraj University
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Chronic kidney disease (CKD) (`cardio:chronic-kidney-disease`)

## Provenance

Content hash: e8dbd66d697bcfd589dd6c1d2b0020ac3adee2019e091eed2888df0fd967dd50
Last substantive edit: 2026-10-26
Evidence last checked: Not recorded
